Atlas Trials

Study to Assess Immunegnicity & Safety of Pentavalent Meningococcal Vaccine (NmCV-5)

Clinical trial NCT03964012 · COMPLETED

Trial details

NCT number
NCT03964012
Sponsor
Serum Institute of India Pvt. Ltd.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Meningococcal Meningitis
Start date
2019-08-20
Primary completion
2020-02-23
Enrollment
1800

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.